User profiles for Joshua Rosenheim

Joshua Rosenheim

Verified email at ucl.ac.uk
Cited by 1061

Immune boosting by B. 1.1. 529 (Omicron) depends on previous SARS-CoV-2 exposure

…, CJ Reynolds, A Richards, M Robathan, J Rosenheim… - Science, 2022 - science.org
The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …

[HTML][HTML] Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

…, S Kucykowicz, G Aidoo-Micah, J Rosenheim… - Nature, 2022 - nature.com
Individuals with potential exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
do not necessarily develop PCR or antibody positivity, suggesting that some …

[HTML][HTML] Genomic investigations of unexplained acute hepatitis in children

…, A Lennon, A McArdle, A Czap, J Rosenheim… - Nature, 2023 - nature.com
Since its first identification in Scotland, over 1,000 cases of unexplained paediatric hepatitis
in children have been reported worldwide, including 278 cases in the UK 1 . Here we report …

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

…, J Jones, M Jones, WYJ Lee, J Rosenheim… - Science …, 2020 - science.org
Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …

[HTML][HTML] Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy …

RK Gupta, J Rosenheim, LC Bell, A Chandran… - The Lancet …, 2021 - thelancet.com
Background We hypothesised that host-response biomarkers of viral infections might
contribute to early identification of individuals infected with SARS-CoV-2, which is critical to …

[PDF][PDF] Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections

A Chandran, J Rosenheim, G Nageswaran… - Cell Reports …, 2022 - cell.com
Effective control of SARS-CoV-2 infection on primary exposure may reveal correlates of
protective immunity to future variants, but we lack insights into immune responses before or at …

Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease

G Pollara, CT Turner, J Rosenheim… - Science translational …, 2021 - science.org
Host immune responses at the site of Mycobacterium tuberculosis infection can mediate
pathogenesis of tuberculosis (TB) and onward transmission of infection. We hypothesized that …

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19

…, A Richards, M Robathan, J Rosenheim… - …, 2022 - Wiley Online Library
SARS‐CoV‐2 infection results in different outcomes ranging from asymptomatic infection to
mild or severe disease and death. Reasons for this diversity of outcome include differences …

[PDF][PDF] Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection

…, T Peacock, A Mayer, A Chandran, J Rosenheim… - Iscience, 2023 - cell.com
T cell responses precede antibody and may provide early control of infection. We analyzed
the clonal basis of this rapid response following SARS-COV-2 infection. We applied T cell …

SARS-CoV-2 human challenge reveals single-gene blood transcriptional biomarkers that discriminate early and late phases of acute respiratory viral infections.

J Rosenheim, RK Gupta, C Thakker, T Mann, LCK Bell… - medRxiv, 2023 - medrxiv.org
Evaluation of host-response blood transcriptional signatures of viral infection have so far
failed to test whether these biomarkers reflect different biological processes that may be …